Corporate Banner
Satellite Banner
Technology Networks Header
Thursday, October 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
FEI Announces Teneo VS for 3D Volume Imaging of Cells and Tissues
Thursday, September 04, 2014
The Teneo VS delivers excellent resolution over large volumes to allow life scientists to explore the structure and interactions of cells and tissues down to the nanometer scale.

Source BioScience Launches Intelligent GenomeCUBE Search Engine
Monday, September 01, 2014
Search and buying tool offers instant, simple access to millions of clone, antibody and protein products.

Waters Launches Progenesis QI Version 2.0 for Small Molecule Data Analysis at IMSC 2014
Monday, August 25, 2014
Next Generation Software Offers Enhanced Control and Function, with Pathway Mapping, Process Automation, and Improved Access to Compound Databases.

BioTek’s Gen5 Software Offers CVB Relative Potency Solution
Thursday, August 14, 2014
Company will describe the use of Gen5 software at webinar on September 25, 2014.

HORIBA Scientific Releases LabSpec 6.3 Software Update
Tuesday, August 12, 2014
Enhanced capabilities include full 3D volume display for Raman spectroscopy.

Optibrium Launches SentiraTM: New Software for Compound Data Visualisation
Monday, August 11, 2014
Powerful desktop application simplifies visualisation, interpretation and presentation of compound data.

IBM Expands High Performance Computing Capabilities in the Cloud
Thursday, July 31, 2014
New option for high performance computing (HPC) available from IBM

ArxLab Notebook Web-based Electronic Notebook
Thursday, July 31, 2014
Arxspan highlights their cloud-based ELN.

Core Informatics Releases Core ELN Chemistry Application on Platform for Science
Monday, July 28, 2014
Newly developed application is designed to help chemists document research activities and compound registration in the cloud.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 859
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv